This survey article illustrates many important current trends and perspectives for the field and their applications, of interest to researchers in modern algebra, mathematical logic and discrete mathematics. It covers...This survey article illustrates many important current trends and perspectives for the field and their applications, of interest to researchers in modern algebra, mathematical logic and discrete mathematics. It covers a number of directions, including completeness theorem and compactness theorem for hyperidentities;the characterizations of the Boolean algebra of n-ary Boolean functions and the bounded distributive lattice of n-ary monotone Boolean functions;the functional representations of finitely-generated free algebras of various varieties of lattices via generalized Boolean functions, etc.展开更多
Cornelia de Lange综合征(CdLS)是一种罕见的先天性畸形疾病,其典型特征包括生长受限、智力迟钝、颅面异常和多毛症等。本研究报道2例CdLS患者,对其临床表现和基因变异特点进行总结,并结合相关文献进行复习。患者1,女性,5岁,因生长发育...Cornelia de Lange综合征(CdLS)是一种罕见的先天性畸形疾病,其典型特征包括生长受限、智力迟钝、颅面异常和多毛症等。本研究报道2例CdLS患者,对其临床表现和基因变异特点进行总结,并结合相关文献进行复习。患者1,女性,5岁,因生长发育缓慢就诊。查体多毛,一字眉,牙齿小、稀疏,前胸、后背可见血管瘤(约2 cm×2 cm),语言发育迟缓,智力落后;身高98 cm [≤-2标准差(SD)],体质量15 kg (-2SD~-1SD),头围46 cm (-3SD~-2SD);脑核磁共振成像(MRI)平扫显示左侧侧脑室侧后角和双侧侧脑室三角略扩大,双侧上颌窦和筛窦黏膜轻度增厚,心脏彩超显示二、三尖瓣轻度反流。患者2,女性,1个月,生后气促,软腭裂,吞咽困难及三凹征阳性,双手小、左手通贯掌、右手第5指短小,右侧髋关节外展受限,双足内翻,右眼底白斑。1个月时超声显示三尖瓣轻度反流,房间隔卵圆孔未闭。2d时脑MRI平扫显示纵裂池及天幕可见少许斑片状低信号影,少量蛛网膜下腔出血,双侧上颌窦、筛窦和中耳乳突少量积液。染色体核型分析未见明显结构及数目异常。全外显子组测序检测,患者1存在NIPBL基因c.6653_6655del杂合变异,患者2存在NIPBL基因c.337C>T杂合变异,父母均未检测到该变异。NIPBL基因变异是CdLS患者的主要遗传学病因,基因变异c.337C>T的鉴定扩展了NIPBL基因的变异谱系,为研究CdLS患者致病性基因变异提供了新证据。展开更多
为实现前沿阵地和地面防空两种典型应用约束条件下到达时间差(Time Difference of Arrival,TDOA)定位的自动布站优化,分析了这两种典型约束条件下的基站长度、站点间角度等对定位精度的影响。提出了基于自适应差分进化(Differential Evo...为实现前沿阵地和地面防空两种典型应用约束条件下到达时间差(Time Difference of Arrival,TDOA)定位的自动布站优化,分析了这两种典型约束条件下的基站长度、站点间角度等对定位精度的影响。提出了基于自适应差分进化(Differential Evolution,DE)算法的TDOA自动布站优化策略。采用该算法对这两种约束条件下的自动布站优化进行了仿真分析,并对自适应DE算法计算复杂度进行了分析。结果表明,自适应DE算法的自动布站复杂度低,收敛快速,与定位误差分析一致,具有较好的全局寻优能力。展开更多
Peste des Petits ruminants (PPR) is considered as one of the major constraints to the productivity of small ruminants in Sudan. Presently, control measures for PPR are primarily reliant on vaccination using an attenua...Peste des Petits ruminants (PPR) is considered as one of the major constraints to the productivity of small ruminants in Sudan. Presently, control measures for PPR are primarily reliant on vaccination using an attenuated PPR strain Nigeria 75/1 that has been produced in monolayers of Vero cells grown in static flasks. This study investigates the potential for scaling up PPR vaccine production using roller bottle technology, a more advanced method. A live, homologous vaccine against PPR in sheep and goats was successfully produced on a large scale in roller culture bottles, with DMEM supplemented with ten percent fetal bovine serum serving as the growth medium. The cells were infected with a multiplicity of infection of 0.01, and the vaccine was harvested when the cytopathic effect reached 80%. The vaccine was then freeze-dried to preserve its stability. A series of tests were conducted to ensure the safety and quality of the vaccine. Using PCR, the identity of vaccine was confirmed. It was found to be safe in both single and 100-times dose inoculations in sheep, with the produced batches showing a high titre of 6.4 ± 0.11 log10 TCID50/ml. All batches met the criteria of sterility, passing tests for bacteria, fungi, and mycoplasma. Furthermore, the vaccine proved effective in small ruminants, with antibodies persisting for over a year post-vaccination. The residual moisture content remained below 2.5%, and the vaccine successfully passed vacuum testing. Stability tests indicated that the vaccine has a shelf-life of at least one year when stored at temperatures of 2˚C - 8˚C and −20˚C. These results demonstrate the potential for applying roller bottle culture technology to PPR vaccine production, significantly streamlining the existing process and enhancing its efficiency. Further research is warranted to address the economic analyses of adopting roller bottle technology with existing PPR control program.展开更多
Peste des petits ruminants virus (PPRV) antibodies were studied in Sudanese sheep and goats (n = 855) before and after vaccination with a locally produced Nigeria 75/1 vaccine using a commercial competitive ELISA (cEL...Peste des petits ruminants virus (PPRV) antibodies were studied in Sudanese sheep and goats (n = 855) before and after vaccination with a locally produced Nigeria 75/1 vaccine using a commercial competitive ELISA (cELISA) kit. Animals were kept healthy under field conditions, in four states: Blue Nile (n = 250), North Kordofan (n = 189), South Darfur (n = 225) and the Northern State (n = 191). Before vaccination, the overall sero-prevalence of PPRV antibodies was 54.6% (53.2% - 56%, 95% CI);high (64.8% - 76.4%, 95% CI) in Blue Nile State, medium (50.5% - 61.9%, 95% CI) in North Kordofan State and South Darfur State and low (28.6% - 35.2% 95%, CI) in Northern State. In high-risk areas (high sero-prevalence), Blue Nile (70.4%) and North Kordofan (57.7%), middle age groups (7 - 12 and 13 - 18 months) were identified as high-risk age. Middle age groups showed lower sero-prevalence than preceding (3 - 6 months) and subsequent (>18 months) age groups while the risk of exposure increased with age. Current and previous findings suggested a transmission pathway of PPRV involving the South Eastern border (Blue Nile) and neighbouring Central Sudan to North Kordofan. One month after vaccination 88.4% (343/388) of sero-negative animals were sero-converted suggesting the efficacy of the locally produced Nigeria 75/1 vaccine. Even if only individuals in the high-risk age group (7 - 18 months) were vaccinated, the overall population immunity (OPI) in high-risk areas (the Blue Nile and North Kordofan) would have surpassed the threshold of 70%, which is indicated for blocking PPRV transmission. However, lower vaccination coverage is expected in wider vaccination programmes. These findings primarily justified the targeting of PPR control in Sudan through the vaccination of high-risk age groups in high-risk areas.展开更多
文摘This survey article illustrates many important current trends and perspectives for the field and their applications, of interest to researchers in modern algebra, mathematical logic and discrete mathematics. It covers a number of directions, including completeness theorem and compactness theorem for hyperidentities;the characterizations of the Boolean algebra of n-ary Boolean functions and the bounded distributive lattice of n-ary monotone Boolean functions;the functional representations of finitely-generated free algebras of various varieties of lattices via generalized Boolean functions, etc.
文摘Cornelia de Lange综合征(CdLS)是一种罕见的先天性畸形疾病,其典型特征包括生长受限、智力迟钝、颅面异常和多毛症等。本研究报道2例CdLS患者,对其临床表现和基因变异特点进行总结,并结合相关文献进行复习。患者1,女性,5岁,因生长发育缓慢就诊。查体多毛,一字眉,牙齿小、稀疏,前胸、后背可见血管瘤(约2 cm×2 cm),语言发育迟缓,智力落后;身高98 cm [≤-2标准差(SD)],体质量15 kg (-2SD~-1SD),头围46 cm (-3SD~-2SD);脑核磁共振成像(MRI)平扫显示左侧侧脑室侧后角和双侧侧脑室三角略扩大,双侧上颌窦和筛窦黏膜轻度增厚,心脏彩超显示二、三尖瓣轻度反流。患者2,女性,1个月,生后气促,软腭裂,吞咽困难及三凹征阳性,双手小、左手通贯掌、右手第5指短小,右侧髋关节外展受限,双足内翻,右眼底白斑。1个月时超声显示三尖瓣轻度反流,房间隔卵圆孔未闭。2d时脑MRI平扫显示纵裂池及天幕可见少许斑片状低信号影,少量蛛网膜下腔出血,双侧上颌窦、筛窦和中耳乳突少量积液。染色体核型分析未见明显结构及数目异常。全外显子组测序检测,患者1存在NIPBL基因c.6653_6655del杂合变异,患者2存在NIPBL基因c.337C>T杂合变异,父母均未检测到该变异。NIPBL基因变异是CdLS患者的主要遗传学病因,基因变异c.337C>T的鉴定扩展了NIPBL基因的变异谱系,为研究CdLS患者致病性基因变异提供了新证据。
文摘为实现前沿阵地和地面防空两种典型应用约束条件下到达时间差(Time Difference of Arrival,TDOA)定位的自动布站优化,分析了这两种典型约束条件下的基站长度、站点间角度等对定位精度的影响。提出了基于自适应差分进化(Differential Evolution,DE)算法的TDOA自动布站优化策略。采用该算法对这两种约束条件下的自动布站优化进行了仿真分析,并对自适应DE算法计算复杂度进行了分析。结果表明,自适应DE算法的自动布站复杂度低,收敛快速,与定位误差分析一致,具有较好的全局寻优能力。
文摘Peste des Petits ruminants (PPR) is considered as one of the major constraints to the productivity of small ruminants in Sudan. Presently, control measures for PPR are primarily reliant on vaccination using an attenuated PPR strain Nigeria 75/1 that has been produced in monolayers of Vero cells grown in static flasks. This study investigates the potential for scaling up PPR vaccine production using roller bottle technology, a more advanced method. A live, homologous vaccine against PPR in sheep and goats was successfully produced on a large scale in roller culture bottles, with DMEM supplemented with ten percent fetal bovine serum serving as the growth medium. The cells were infected with a multiplicity of infection of 0.01, and the vaccine was harvested when the cytopathic effect reached 80%. The vaccine was then freeze-dried to preserve its stability. A series of tests were conducted to ensure the safety and quality of the vaccine. Using PCR, the identity of vaccine was confirmed. It was found to be safe in both single and 100-times dose inoculations in sheep, with the produced batches showing a high titre of 6.4 ± 0.11 log10 TCID50/ml. All batches met the criteria of sterility, passing tests for bacteria, fungi, and mycoplasma. Furthermore, the vaccine proved effective in small ruminants, with antibodies persisting for over a year post-vaccination. The residual moisture content remained below 2.5%, and the vaccine successfully passed vacuum testing. Stability tests indicated that the vaccine has a shelf-life of at least one year when stored at temperatures of 2˚C - 8˚C and −20˚C. These results demonstrate the potential for applying roller bottle culture technology to PPR vaccine production, significantly streamlining the existing process and enhancing its efficiency. Further research is warranted to address the economic analyses of adopting roller bottle technology with existing PPR control program.
文摘Peste des petits ruminants virus (PPRV) antibodies were studied in Sudanese sheep and goats (n = 855) before and after vaccination with a locally produced Nigeria 75/1 vaccine using a commercial competitive ELISA (cELISA) kit. Animals were kept healthy under field conditions, in four states: Blue Nile (n = 250), North Kordofan (n = 189), South Darfur (n = 225) and the Northern State (n = 191). Before vaccination, the overall sero-prevalence of PPRV antibodies was 54.6% (53.2% - 56%, 95% CI);high (64.8% - 76.4%, 95% CI) in Blue Nile State, medium (50.5% - 61.9%, 95% CI) in North Kordofan State and South Darfur State and low (28.6% - 35.2% 95%, CI) in Northern State. In high-risk areas (high sero-prevalence), Blue Nile (70.4%) and North Kordofan (57.7%), middle age groups (7 - 12 and 13 - 18 months) were identified as high-risk age. Middle age groups showed lower sero-prevalence than preceding (3 - 6 months) and subsequent (>18 months) age groups while the risk of exposure increased with age. Current and previous findings suggested a transmission pathway of PPRV involving the South Eastern border (Blue Nile) and neighbouring Central Sudan to North Kordofan. One month after vaccination 88.4% (343/388) of sero-negative animals were sero-converted suggesting the efficacy of the locally produced Nigeria 75/1 vaccine. Even if only individuals in the high-risk age group (7 - 18 months) were vaccinated, the overall population immunity (OPI) in high-risk areas (the Blue Nile and North Kordofan) would have surpassed the threshold of 70%, which is indicated for blocking PPRV transmission. However, lower vaccination coverage is expected in wider vaccination programmes. These findings primarily justified the targeting of PPR control in Sudan through the vaccination of high-risk age groups in high-risk areas.
